Medherant, a University of Warwick spin-out company, developing transdermal drug delivery patch technology, has announced the appointment of Sheryl Caswell as head of clinical development. Read more


The software developer for cell and gene therapy supply chain tracking and orchestration, TrakCel, has announced the appointment of Dr Anthony Davies to strengthen its position and triple revenue by the end of the year. Read more


Contract development and manufacturing organisation (CDMO), Recipharm, has announced the strategic appointment in the UK and Ireland of Shabbir Mostafa. Mostafa will join the business management team as director. Read more


Drug development company, Aelix Therapeutics, has appointed HIV expert, Dr Ian McGowan, as chief medical officer (CMO). Read more


Bill Sibold has been appointed as executive vice president of Sanofi Genzyme with effect from 1 July. In this role, he will also be a member of the executive committee. Read more


UK-based Ergomed, dedicated to the provision of services for developing new drugs, has appointed Andrew Mackie as chief business officer and to its board as executive director. Read more


Alan Hirzel will succeed long-serving chief executive and co-founder of Abcam Jonathan Milner, who will continue to play an active role in the company as deputy chairman. Read more

Alison will be responsible for Exova’s Edinburgh and Camberley laboratories, utilising her operational experience, technical knowledge and solid understanding of the regulatory framework in which Exova’s customers operate. Read more

Monge will focus on sharpening SSB’s profile as an integrated solution provider for the biopharmaceutical industry. Read more

In this newly-created role Olivier will oversee commercial activities in the fast-moving Asian market for GE Healthcare Life Science’s rapidly growing bioprocess business. Read more

Simon Dew has been appointed to chief strategy officer and Jun Kono becomes vice president, corporate strategy & communications. Read more

Dr Chachad is an expert in the design and execution of preclinical and clinical development programme for drug products across dosage forms and therapeutic categories. Read more

Adam Burgess's expertise reaches across both commercial and clinical trial products including steriles, non-sterile tablets, capsules and liquids. Read more

Dr Emmanuelle Charpentier, Dr J. Keith Joung, and Dr Feng Zhang join Horizon’s panel of expert gene editing advisors. Read more

Aesica has appointment of Nadine K. Reuter to the position of business development manager, finished dose with responsibility for assisting in the drive to expand revenues from contract manufacturing activities across Germany, Austria and Switzerland Read more

The appointment further expands the growing business development team at Confab. Gudz will implement strategies and tactics to enrich the experience for the company’s current clients, strengthen existing partnerships and grow its client base Read more

With extensive business development and project delivery experience in the pharma and CRO/CMO market, Mark brings in-depth understanding of the scientific, regulatory and time-pressured nature of projects in drug development and clinical trials Read more